469 related articles for article (PubMed ID: 26876955)
1. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
2. Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study.
Kirchheiner K; Nout RA; Czajka-Pepl A; Ponocny-Seliger E; Sturdza AE; Dimopoulos JC; Dörr W; Pötter R
Gynecol Oncol; 2015 Mar; 136(3):415-23. PubMed ID: 25462202
[TBL] [Abstract][Full Text] [Related]
3. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer.
Heijkoop ST; Nout RA; Quint S; Mens JWM; Heijmen BJM; Hoogeman MS
Gynecol Oncol; 2017 Nov; 147(2):439-449. PubMed ID: 28830646
[TBL] [Abstract][Full Text] [Related]
5. Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
Seppenwoolde Y; Majercakova K; Buschmann M; Dörr E; Sturdza AE; Schmid MP; Pötter R; Georg D
Strahlenther Onkol; 2021 Jun; 197(6):505-519. PubMed ID: 33929558
[TBL] [Abstract][Full Text] [Related]
6. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
[TBL] [Abstract][Full Text] [Related]
7. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
Kirchheiner K; Smet S; Jürgenliemk-Schulz IM; Haie-Meder C; Chargari C; Lindegaard JC; Fokdal LU; Spampinato S; Schmid MP; Sturdza A; Mahantshetty U; Segedin B; Bruheim K; Rai B; Cooper R; Van der Steen-Banasik E; Wiebe E; Sundset M; van Limbergen E; Villafranca E; Westerveld H; Tan LT; Pötter R; Tanderup K; Nout RA;
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):400-413. PubMed ID: 34478833
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study.
Vittrup AS; Tanderup K; Bentzen SM; Jensen NBK; Spampinato S; Fokdal LU; Lindegaard JC; Sturdza A; Schmid M; Segedin B; Jürgenliemk-Schulz IM; Bruheim K; Mahantshetty U; Haie-Meder C; Rai B; Cooper R; van der Steen-Banasik E; Sundset M; Huang F; Nout RA; Villafranca E; Van Limbergen E; Pieters BR; Tan LT; Lutgens LCHW; Hoskin P; Pötter R; Kirchheiner K;
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):161-173. PubMed ID: 32853710
[TBL] [Abstract][Full Text] [Related]
9. Quality of life characteristics inpatients with cervical cancer.
Bjelic-Radisic V; Jensen PT; Vlasic KK; Waldenstrom AC; Singer S; Chie W; Nordin A; Greimel E
Eur J Cancer; 2012 Nov; 48(16):3009-18. PubMed ID: 22683166
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life of Patients with Advanced Cervical Cancer before and after Chemoradiotherapy.
Dahiya N; Acharya AS; Bachani D; Sharma D; Gupta S; Haresh K; Rath G
Asian Pac J Cancer Prev; 2016; 17(7):3095-9. PubMed ID: 27509935
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer.
Gargiulo P; Arenare L; Pisano C; Cecere SC; Falivene S; Greggi S; Tambaro R; Facchini G; De Palma G; Scaffa C; Della Pepa C; Pignata S; Di Napoli M
Oncology; 2016; 90(1):29-35. PubMed ID: 26473609
[TBL] [Abstract][Full Text] [Related]
12. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
Jensen NBK; Pötter R; Kirchheiner K; Fokdal L; Lindegaard JC; Kirisits C; Mazeron R; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K;
Radiother Oncol; 2018 Jun; 127(3):431-439. PubMed ID: 29880222
[TBL] [Abstract][Full Text] [Related]
13. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
Smet S; Pötter R; Haie-Meder C; Lindegaard JC; Schulz-Juergenliemk I; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van Limbergen E; Tanderup K; Kirchheiner K;
Radiother Oncol; 2018 Jun; 127(3):440-448. PubMed ID: 29627137
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.
Ferrandina G; Mantegna G; Petrillo M; Fuoco G; Venditti L; Terzano S; Moruzzi C; Lorusso D; Marcellusi A; Scambia G
Gynecol Oncol; 2012 Mar; 124(3):389-94. PubMed ID: 22035809
[TBL] [Abstract][Full Text] [Related]
15. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract][Full Text] [Related]
16. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
17. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
K Jensen NB; Pötter R; Spampinato S; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Van der Steen-Banasik E; Van Limbergen E; Sundset M; Pieters BR; Nout RA; Kirisits C; Kirchheiner K; Tanderup K;
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):688-700. PubMed ID: 33068689
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population.
Park SY; Bae DS; Nam JH; Park CT; Cho CH; Lee JM; Lee MK; Kim SH; Park SM; Yun YH
Cancer; 2007 Dec; 110(12):2716-25. PubMed ID: 17960806
[TBL] [Abstract][Full Text] [Related]
20. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
